A comprehensive in silico and invitro analysis revealed the diagnostic, prognostic and therapeutic potential of GNAI family genes in colon adenocarcinoma (COAD)

Abstract Introduction Guanine nucleotide-binding protein alpha inhibiting activity polypeptides (GNAI1, GNAI2, and GNAI3) play critical roles in cell cycle regulation, intracellular signaling, and immune modulation. However, their contribution to colorectal adenocarcinoma (COAD) pathogenesis remains...

Full description

Saved in:
Bibliographic Details
Main Authors: Bei Wang, Fan Zhu, Yingying Chen
Format: Article
Language:English
Published: BMC 2025-08-01
Series:Hereditas
Subjects:
Online Access:https://doi.org/10.1186/s41065-025-00523-3
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849330494157619200
author Bei Wang
Fan Zhu
Yingying Chen
author_facet Bei Wang
Fan Zhu
Yingying Chen
author_sort Bei Wang
collection DOAJ
description Abstract Introduction Guanine nucleotide-binding protein alpha inhibiting activity polypeptides (GNAI1, GNAI2, and GNAI3) play critical roles in cell cycle regulation, intracellular signaling, and immune modulation. However, their contribution to colorectal adenocarcinoma (COAD) pathogenesis remains poorly defined. This study aimed to comprehensively evaluate the diagnostic, prognostic, and therapeutic relevance of GNAI genes in COAD through integrated in silico and in vitro analyses. Methods mRNA and protein expression profiles of GNAI1, GNAI2, and GNAI3 were analyzed using TCGA, OncoDB, HPA databases, and RT-qPCR analysis across COAD cell lines. Genetic and epigenetic alterations were assessed using UALCAN, cBioPortal, and GSCA databases. Prognostic significance was evaluated through Kaplan–Meier survival and GENT2 databases. Potential miRNA regulators were identified via TargetScan and quantified using TaqMan assays. Immune interactions, immune infiltration, and drug sensitivity were examined using TISIDB and GSCA platforms. Functional effects of GNAI1 and GNAI2 overexpression were tested in SW480 and HCT116 cell lines using proliferation, colony formation, and wound healing assays. Results GNAI1, GNAI2, and GNAI3 were significantly downregulated in both COAD tissues and cell lines. This downregulation correlated with promoter hypermethylation, CNV deletions, and reduced patient survival. ROC analysis indicated better diagnostic potential, particularly for GNAI2 (AUC = 0.83). Pathway analysis revealed suppression of DNA damage and cell cycle regulatory pathways and activation of EMT-related signaling. Upregulated miRNAs—hsa-miR-133a-3p-1, hsa-miR-138-5p, and hsa-miR-141-3p—were identified as direct regulators, exhibiting strong diagnostic capacity. Immune profiling showed that GNAI genes were differentially expressed across immune subtypes, negatively correlated with immune inhibitors, and positively associated with stimulators. Overexpression of GNAI1 and GNAI2 significantly inhibited COAD cell proliferation, clonogenic potential, and migration. Conclusion This study reveals the tumor-suppressive function of GNAI1, GNAI2, and GNAI3 in COAD through genetic, epigenetic, and miRNA-mediated regulation. Their downregulation is associated with poor prognosis, altered immune landscape, and therapy resistance. Restoration of GNAI function represents a promising avenue for diagnostic and therapeutic intervention in colorectal cancer. Clinical trial number None.
format Article
id doaj-art-bc30a4a12aed4a37a4fd03b87ebd0f6c
institution Kabale University
issn 1601-5223
language English
publishDate 2025-08-01
publisher BMC
record_format Article
series Hereditas
spelling doaj-art-bc30a4a12aed4a37a4fd03b87ebd0f6c2025-08-20T03:46:54ZengBMCHereditas1601-52232025-08-01162111910.1186/s41065-025-00523-3A comprehensive in silico and invitro analysis revealed the diagnostic, prognostic and therapeutic potential of GNAI family genes in colon adenocarcinoma (COAD)Bei Wang0Fan Zhu1Yingying Chen2Anorectal surgery, The People’s Hospital of DanyangDepartment of General Surgery, Ezhou Central HospitalDepartment of Gastroenterology, Affiliated Hospital of Xuzhou Medical UniversityAbstract Introduction Guanine nucleotide-binding protein alpha inhibiting activity polypeptides (GNAI1, GNAI2, and GNAI3) play critical roles in cell cycle regulation, intracellular signaling, and immune modulation. However, their contribution to colorectal adenocarcinoma (COAD) pathogenesis remains poorly defined. This study aimed to comprehensively evaluate the diagnostic, prognostic, and therapeutic relevance of GNAI genes in COAD through integrated in silico and in vitro analyses. Methods mRNA and protein expression profiles of GNAI1, GNAI2, and GNAI3 were analyzed using TCGA, OncoDB, HPA databases, and RT-qPCR analysis across COAD cell lines. Genetic and epigenetic alterations were assessed using UALCAN, cBioPortal, and GSCA databases. Prognostic significance was evaluated through Kaplan–Meier survival and GENT2 databases. Potential miRNA regulators were identified via TargetScan and quantified using TaqMan assays. Immune interactions, immune infiltration, and drug sensitivity were examined using TISIDB and GSCA platforms. Functional effects of GNAI1 and GNAI2 overexpression were tested in SW480 and HCT116 cell lines using proliferation, colony formation, and wound healing assays. Results GNAI1, GNAI2, and GNAI3 were significantly downregulated in both COAD tissues and cell lines. This downregulation correlated with promoter hypermethylation, CNV deletions, and reduced patient survival. ROC analysis indicated better diagnostic potential, particularly for GNAI2 (AUC = 0.83). Pathway analysis revealed suppression of DNA damage and cell cycle regulatory pathways and activation of EMT-related signaling. Upregulated miRNAs—hsa-miR-133a-3p-1, hsa-miR-138-5p, and hsa-miR-141-3p—were identified as direct regulators, exhibiting strong diagnostic capacity. Immune profiling showed that GNAI genes were differentially expressed across immune subtypes, negatively correlated with immune inhibitors, and positively associated with stimulators. Overexpression of GNAI1 and GNAI2 significantly inhibited COAD cell proliferation, clonogenic potential, and migration. Conclusion This study reveals the tumor-suppressive function of GNAI1, GNAI2, and GNAI3 in COAD through genetic, epigenetic, and miRNA-mediated regulation. Their downregulation is associated with poor prognosis, altered immune landscape, and therapy resistance. Restoration of GNAI function represents a promising avenue for diagnostic and therapeutic intervention in colorectal cancer. Clinical trial number None.https://doi.org/10.1186/s41065-025-00523-3COADGNAI genesPrognosisTherapeutic target
spellingShingle Bei Wang
Fan Zhu
Yingying Chen
A comprehensive in silico and invitro analysis revealed the diagnostic, prognostic and therapeutic potential of GNAI family genes in colon adenocarcinoma (COAD)
Hereditas
COAD
GNAI genes
Prognosis
Therapeutic target
title A comprehensive in silico and invitro analysis revealed the diagnostic, prognostic and therapeutic potential of GNAI family genes in colon adenocarcinoma (COAD)
title_full A comprehensive in silico and invitro analysis revealed the diagnostic, prognostic and therapeutic potential of GNAI family genes in colon adenocarcinoma (COAD)
title_fullStr A comprehensive in silico and invitro analysis revealed the diagnostic, prognostic and therapeutic potential of GNAI family genes in colon adenocarcinoma (COAD)
title_full_unstemmed A comprehensive in silico and invitro analysis revealed the diagnostic, prognostic and therapeutic potential of GNAI family genes in colon adenocarcinoma (COAD)
title_short A comprehensive in silico and invitro analysis revealed the diagnostic, prognostic and therapeutic potential of GNAI family genes in colon adenocarcinoma (COAD)
title_sort comprehensive in silico and invitro analysis revealed the diagnostic prognostic and therapeutic potential of gnai family genes in colon adenocarcinoma coad
topic COAD
GNAI genes
Prognosis
Therapeutic target
url https://doi.org/10.1186/s41065-025-00523-3
work_keys_str_mv AT beiwang acomprehensiveinsilicoandinvitroanalysisrevealedthediagnosticprognosticandtherapeuticpotentialofgnaifamilygenesincolonadenocarcinomacoad
AT fanzhu acomprehensiveinsilicoandinvitroanalysisrevealedthediagnosticprognosticandtherapeuticpotentialofgnaifamilygenesincolonadenocarcinomacoad
AT yingyingchen acomprehensiveinsilicoandinvitroanalysisrevealedthediagnosticprognosticandtherapeuticpotentialofgnaifamilygenesincolonadenocarcinomacoad
AT beiwang comprehensiveinsilicoandinvitroanalysisrevealedthediagnosticprognosticandtherapeuticpotentialofgnaifamilygenesincolonadenocarcinomacoad
AT fanzhu comprehensiveinsilicoandinvitroanalysisrevealedthediagnosticprognosticandtherapeuticpotentialofgnaifamilygenesincolonadenocarcinomacoad
AT yingyingchen comprehensiveinsilicoandinvitroanalysisrevealedthediagnosticprognosticandtherapeuticpotentialofgnaifamilygenesincolonadenocarcinomacoad